Eton Pharmaceuticals, Inc. (ETON)
32.48
+1.53
(+4.94%)
USD |
NASDAQ |
Jun 11, 15:23
Eton Pharmaceuticals Max Drawdown (5Y) : 79.94% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 79.94% |
| April 30, 2026 | 79.94% |
| March 31, 2026 | 79.94% |
| February 28, 2026 | 79.94% |
| January 31, 2026 | 79.94% |
| December 31, 2025 | 79.94% |
| November 30, 2025 | 79.94% |
| October 31, 2025 | 79.94% |
| September 30, 2025 | 79.94% |
| August 31, 2025 | 79.94% |
| July 31, 2025 | 79.94% |
| June 30, 2025 | 79.94% |
| May 31, 2025 | 79.94% |
| April 30, 2025 | 79.94% |
| March 31, 2025 | 79.94% |
| February 28, 2025 | 79.94% |
| January 31, 2025 | 79.94% |
| December 31, 2024 | 79.94% |
| November 30, 2024 | 79.94% |
| October 31, 2024 | 79.94% |
| September 30, 2024 | 79.94% |
| August 31, 2024 | 79.94% |
| July 31, 2024 | 79.94% |
| June 30, 2024 | 79.94% |
| May 31, 2024 | 79.94% |
| Date | Value |
|---|---|
| April 30, 2024 | 79.94% |
| March 31, 2024 | 79.94% |
| February 29, 2024 | 79.94% |
| January 31, 2024 | 79.94% |
| December 31, 2023 | 79.94% |
| November 30, 2023 | 79.94% |
| October 31, 2023 | 79.94% |
| September 30, 2023 | 79.94% |
| August 31, 2023 | 79.94% |
| July 31, 2023 | 79.94% |
| June 30, 2023 | 79.94% |
| May 31, 2023 | 79.94% |
| April 30, 2023 | 79.94% |
| March 31, 2023 | 79.94% |
| February 28, 2023 | 79.94% |
| January 31, 2023 | 79.94% |
| December 31, 2022 | 79.94% |
| November 30, 2022 | 79.94% |
| October 31, 2022 | 79.94% |
| September 30, 2022 | 79.74% |
| August 31, 2022 | 77.56% |
| July 31, 2022 | 74.68% |
| June 30, 2022 | 74.68% |
| May 31, 2022 | 71.30% |
| April 30, 2022 | 67.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Daré Bioscience, Inc. | 96.17% |
| Tarsus Pharmaceuticals, Inc. | 77.67% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Assertio Holdings, Inc. | 99.16% |